NCI is on the cusp of releasing designs for its National Cancer Plan, an initiative that would guide the institute’s mission and portfolio for years to come and engage everyone in oncology to “end cancer as we know it,” said NCI Director Monica Bertagnolli.
The FY23 Defense Appropriations Act provides funding for the Peer Reviewed Cancer Research Program to support innovative, high-impact cancer research. The managing agent for the anticipated funding opportunities is the CDMRP at the U.S. Army Medical Research and Development Command.
The FY23 Defense Appropriations Act provides funding for the Pancreatic Cancer Research Program to support research of exceptional scientific merit and innovation with high impact that focuses on pancreatic cancer.
NCI and Cancer Research UK announced nine new research challenges aimed at tackling some of the most profound problems in cancer research. The global funding opportunity is part of the Cancer Grand Challenges program, an initiative launched by NCI and Cancer Research UK in 2020.
The FY23 Defense Appropriations Act provides funding for the Bone Marrow Failure Research Program to support innovative, high-impact bone marrow failure research. The managing agent for the anticipated funding opportunities is the CDMRP at the U.S. Army Medical Research and Development Command.
The FY23 Defense Appropriations Act provides funding for the Prostate Cancer Research Program to support innovative, high-impact prostate cancer research.
The FY23 Defense Appropriations Act provides funding for the Melanoma Research Program to support innovative, high-impact melanoma research.
Mark Haynes Smith died Nov. 3, 2022. He was my partner and husband for just shy of 39 years. He was only 63.
The Mark Foundation for Cancer Research granted ASPIRE awards of twelve research projects from academic institutions in Germany, Israel, Netherlands, Spain, and USA, totaling more than $4 million.
The governing board of the Cancer Prevention and Research Institute of Texas approved over $90 million in cancer research and prevention grants at its quarterly meeting on Feb. 15. The slate of forty projects from across Texas fund a wide range of research and prevention efforts at major research hubs like Dallas, San Antonio, and Houston, but also invests in rapidly developing cancer research programs in El Paso and the Rio Grande Valley.
